Artiva Biotherapeutics, Inc. (ARTV) — DEF 14A Filings
All DEF 14A filings from Artiva Biotherapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Artiva Biotherapeutics Files Definitive Proxy Statement
— Apr 29, 2025 Risk: low
Artiva Biotherapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its fiscal year ending December 31, 2024. The filing pertains
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX